Verified Nov 2026
Other
·
Brussels, Brussels
·
Since 1951
SERB Pharmaceuticals is a specialty pharmaceutical company founded in 1951 and headquartered in Brussels, Belgium. With 500–1,000 employees and estimated revenue of $100–250 million, the privately held firm develops and manufactures essential medicines for critical care, medical emergencies, and rare diseases. The company operates in over 100 countries and recently acquired European and Middle Eastern/North African rights to imlifidase, a treatment for organ transplant rejection.
Serb Pharmaceuticals at a glance
Revenue
$100-250M
Est. band
Employees
500-1,000
Founded
1951
Headquarters
Brussels, Brussels
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
SERB Pharmaceuticals is a specialty pharmaceutical company founded in 1951 and headquartered in Brussels, Belgium. With 500–1,000 employees and estimated revenue of $100–250 million, the privately held firm develops and manufactures essential medicines for critical care, medical emergencies, and rare diseases. The company operates in over 100 countries and recently acquired European and Middle Eastern/North African rights to imlifidase, a treatment for organ transplant rejection.
At a glance
Attribute | Detail |
|---|---|
Founded | 1951 |
Headquarters | Brussels, Brussels |
Employees | 500-1,000 |
Revenue | $100-250M (estimated) |
What Serb Pharmaceuticals makes
SERB specializes in niche-branded prescription drugs, antidotes for medical emergencies, and rare disease treatments, with a focus on critical care and biologic manufacturing capabilities.
Products and capabilities described on the company's own site include Emissions, Seal (source: serb.com).
Latest developments
2026-07-01 — SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma - SERB Pharmaceuticals (serb.com)
2026-05-29 — SERB Sizes Up €1bn Sales With M&A Savoir Faire (citeline.com)
2026-05-19 — SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million - SERB Pharmaceuticals (serb.com)
2026-01-12 — SERB Pharmaceuticals Expands Scientific Leadership with Appointment of Dr. Peter C. Adamson to US Board - SERB Pharmaceuticals (serb.com)
2025-11-18 — Partnership and Preparedness in a Volatile World - NCT CBNW (nct-cbnw.com)
2025-11-17 — Dr. Vignesh Rajah Appointed as SERB Pharmaceuticals’ Chief Medical Officer - SERB Pharmaceuticals (serb.com)
Facilities
Serb Pharmaceuticals is headquartered in Brussels, Brussels. Public sources also reference these locations:
Brussels, Belgium — citeline.com
Hattiesburg, Mississippi — serb.com
Company details
The privately owned group operates across over 100 countries and serves healthcare providers, government agencies, and emergency responders through a global sales network. Serb Pharmaceuticals was founded in 1951, has an estimated 500-1,000 employees, and is headquartered in Brussels, Brussels.
Frequently asked questions
What does Serb Pharmaceuticals do?
SERB Pharmaceuticals is a specialty pharmaceutical company founded in 1951 and headquartered in Brussels, Belgium. With 500–1,000 employees and estimated revenue of $100–250 million, the privately held firm develops and manufactures essential medicines for critical care, medical emergencies, and rare diseases. The company operates in over 100 countries and recently acquired European and Middle Eastern/North African rights to imlifidase, a treatment for organ transplant rejection.
Where is Serb Pharmaceuticals headquartered?
Serb Pharmaceuticals is headquartered in Brussels, Brussels (480 Avenue Louise, Brussels, Brussels, 1050).
When was Serb Pharmaceuticals founded?
Serb Pharmaceuticals was founded in 1951.
How big is Serb Pharmaceuticals?
Serb Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
